Clinical Trial Update: Study of NST-6179 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study of NST-6179 in healthy subjects has been completed, with results posted. The trial evaluated safety and tolerability in the contexts of Short Bowe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parenteral Nutrition Associated Liver Disease
• Short Bowel Syndrome

Drugs mentioned

• NST-6179 (NST-6179)

Snippet

Sponsor: NorthSea Therapeutics B.V. | Conditions: Short Bowel Syndrome, Parenteral Nutrition Associated Liver Disease | Phase 1 | Status: COMPLETED | Results posted: 2024-06-24